University of Virginia-Center for Diabetes Technology

Charlottesville, Virginia 22908

6 studies enrolling now · 55 studies all time

What they study most

Cystic Fibrosis-related Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 1, Hyperglycemia, Hypoglycemia, Islet Transplantation, Type 1 Diabetes, Type 1 Diabetes (T1D), Type 1 Diabetes Mellitis, Type 1 Diabetes Mellitus, Type 2 Diabetes, Type 2 Diabetes Mellitus

Studies at this site

• Bionic Pancreas in CFRD — Recruiting now
• Insulin Delivery With Self-Adjusting Closed-Loop and Behavioral Glycemic Control Enhanced by Prediction — Recruiting now
• Treating Early Type 2 Diabetes by Reducing Postprandial Glucose Excursions: A Paradigm Shift in Lifestyle Modification — Recruiting now
• A Randomized Parallel Clinical Trial of AIDANET, an Automated Insulin Delivery Algorithm, in Fully Closed-Loop Vs Hybrid Closed-Loop Mode In Adults With Type 1 Diabetes (AIDANET At Home) — Recruiting now
• Patient Centered Multi-Agent Decision Support System (PCM-DSS) for Healthcare Providers — Recruiting now
• Adaptive Biobehavioral Control (ABC) in a Closed-Loop System — Completed
• Early Feasibility Study of Adaptive Advisory/Automated (AAA) Control of Type 1 Diabetes — Stopped early
• AIDANET Pediatrics — Running, not enrolling
• Safety and Feasibility of a Machine-Learning Bolus Priming Added to Existing Control Algorithm — Completed
• InsuLearn Feasibility With Type 1 Diabetes Patients Under MDI Therapy — Completed
• Automated Insulin Delivery (AID) for Basal Insulin Titration in Type 2 Diabetes — Completed
• Safety and Feasibility of a Self-Learning Bolus Calculator With Simplified Meal Announcement in Adolescents With Type 1 Diabetes Using Automated Insulin Delivery — Completed
• Effectiveness of Artificial-Intelligence (AI) Bolus Priming Added to an Existing Fully Automated Control Algorithm (AIDANET) — Starting soon
• Testing a Conversion Factor for a More Rapidly Acting Insulin in an Automated Insulin Delivery System Among Adolescents With T1D — Completed
• Artificial Pancreas - Adolescent Physiology & Psychology Longitudinal Evaluation — Completed
• Adapting Diabetes Treatment Expert Systems to Patient in Type 1 Diabetes — Completed
• Evaluation of The Postprandial Impact of Automated Priming Bolus for Full Closed Loop Insulin Delivery — Completed
• Web-Based Simulation Tool For Self-Management Support In Type 1 Diabetes Mellitus — Completed
• Adaptive Biobehavioral Control (ABC) of Automated Insulin Delivery — Completed
• Artificial Pancreas and Remote Monitoring During a T1DM Youth Ski Camp — Completed
• Feasibility of a Decision Support System to Reduce Glucose Variability in Subject With T1DM — Completed
• Safety and Efficacy of Initializing the Control-IQ Artificial Pancreas System Using Total Daily Insulin — Completed
• Neural-net Artificial Pancreas (NAP) — Completed
• Hybrid Closed-Loop Control With Smart Prandial Insulin Dosing in Type 1 Diabetes — Completed
• Diabetes Closed-Loop Project 6 (DCLP6): Fully Automated Closed-Loop Control in Type 1 Diabetes Using Meal Anticipation — Completed
• CloudConnect: Predictive And Retrospective Clinical Decision Support For Chronic Disease Management — Completed
• Closed Loop Control in Adolescents Using Heart Rate as Exercise Indicator — Completed
• The Pediatric Artificial Pancreas (PEDAP) Trial of Control-IQ Technology in Young Children in Type 1 Diabetes — Completed
• Evaluation of Updated Continuous Glucose Monitoring (CGM) Form Factor in Adults, Adolescents and Pediatrics — Completed
• Safety of Artificial Pancreas Therapy in Preschoolers, Age 2-6 — Completed
• The International Diabetes Closed Loop (iDCL) Trial: Protocol 1 — Completed
• USS Virginia Closed-Loop Versus SAP Therapy for Hypoglycemia Reduction in T1D — Completed
• Optimizing Closed-Loop Control of Type 1 Diabetes Mellitus in Adolescents — Completed
• The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas (DCLP3 Extension) — Completed
• SGLT2 Inhibitor Adjunctive Therapy to Closed Loop Control in Type 1 Diabetes Mellitus — Completed
• A Pilot Test of t:Slim X2 With Control-IQ Technology — Completed
• Fully Automated Closed Loop Control in Adolescents With Type 1 Diabetes — Completed
• Glycemic Profiles And Insulin Delivery Across The Menstrual Cycle In Women With Type 1 Diabetes — Completed
• Glucagon Counterregulation in Type 1 Diabetes — Stopped early
• CGM Use in Islet Transplant Recipients — Completed
• Project Nightlight: Efficacy and System Acceptance of Dinner/Night vs. 24hr Closed Loop Control — Completed
• The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas — Completed
• USS Virginia Closed-Loop for Overnight Control in Type 1 Diabetes — Completed
• Development of an Advisory System for Glycemic Control During the Menstrual Cycle in Patient With Type 1 Diabetes — Completed
• Insulin-Glucose-Glucagon Network: Defining a Type 1 Diabetes Progression Index — Completed
• Exercise Activity-Based Bolus Decisions in Type 1 Diabetes — Completed
• International Diabetes Closed Loop (iDCL) Trial: Research Site Training Protocol — Completed
• Closed-Loop Control in Young Children 5-8 Years Old Using DiAs Platform — Completed
• Insulin Sensitivity, Impaired Counterregulation, and Glucose Variability — Completed
• Development of a Comprehensive AP Training Curriculum for Adults — Completed